Jensen, Lippman, Theodorescu Join AACI Board
Source Newsroom: Association of American Cancer Institutes (AACI)
Newswise — The Association of American Cancer Institutes (AACI) congratulates Roy A. Jensen, MD, Scott M. Lippman, MD, and Dan Theodorescu, MD, PhD, on their election to the AACI Board of Directors.
Dr. Jensen leads The University of Kansas Cancer Center. Since becoming director in 2004, he has recruited a top leadership team that achieved National Cancer Institute (NCI) designation for the Center in 2012. Before moving to Kansas, Dr. Jensen was part of the leadership team that helped the Vanderbilt-Ingram Cancer Center gain NCI designation.
Dr. Lippman joined the UC San Diego Moores Cancer Center, an NCI-designated comprehensive cancer center, as director in May 2012. He is a professor of medicine and holds the Chugai Pharmaceutical Chair in Cancer at UCSD. Previously, he was chair of the Departments of Clinical Cancer Prevention and Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center.
Dr. Theodorescu is the Paul Bunn Professor and Director of the NCI designated Consortium Comprehensive Cancer Center at the University of Colorado. He is also Professor of Surgery and Pharmacology and Attending Urologic Oncologist with a focused clinical practice in bladder cancer and minimally invasive robotic surgery.
The directors’ three-year terms will commence on September 29 during the AACI/CCAF annual meeting. AACI and the Cancer Center Administrators Forum (CCAF) jointly formulated the program for the meeting, which will be held September 29 - October 1 at the Mandarin Oriental Hotel in Washington, D.C. More information on the meeting, including the program and electronic registration, is available at AACI’s website, www.aaci-cancer.org.
Representing 95 of the nation’s premier academic and free-standing cancer research centers, the Association of American Cancer Institutes is dedicated to promoting leading research institutions' efforts to eradicate cancer through a comprehensive and multidisciplinary program of cancer research, treatment, patient care, prevention, education and community outreach.